Congresswoman Nancy Pelosi (D-Calif.) beat the stock market in 2025 with her investment portfolio posting gains once again.

By the close of trading, Tempus AI's stock price was up more than 4% after rising as much as 15% earlier in the day. Tempus ...

TEM has surged 105% in a year on AI-driven growth, FDA clearances and improving margins, but GAAP losses still cloud the ...

Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M ...

Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.

Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...

If you are wondering whether Tempus AI's current share price reflects its underlying worth, you are not alone. This article ...

Tempus AI partners with NYU Langone Health and Northwestern Medicine to broaden access to genomic testing, enhancing ...

Only time will tell if the market enthusiasm that drove artificial intelligence (AI) stocks higher in 2024 will extend through 2025. But one ticker that may be less recognizable among the AI crowd is ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock surged 12% Monday after the precision medicine technology company announced it achieved a record total contract value (TCV) exceeding $1.1 billion ...

Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF.